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Abstract 
The effects of nitric oxide produced by macrophage-like cells (Mml) on the cell cycle were investigated. Mm1 cells lost proliferative activity in 
the presence of interleukin-6 (IL-Q and a subpopulation accumulated in the G,+M phase. This level increased in proportion to the incubation time. 
The DNA content of the cells was slightly lower than that of Mm1 cells treated with vinbrastine or demecolcine, drugs which block the cell cycle 
in the M phase. The peak of the early G,+M phase was reduced by treatment with NG-mono-methyl-L-arginine. However, after treatment with 
exogenous nitric oxide or sodium nitroprusside, the G$G, phase increased, but the early-G>+M and the S phase decreased. The flow cytometry pattern 
in II&treated Mm1 was the same as that of cytochalasin B-treated Mml. These data suggest hat endogenous nitric oxide affects the microfilament 
system of IL-&treated Mm1 cells and blocks the cell cycle in the early G,+M phase. 
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1. Introduction 
Cell growth, differentiation and apoptosis (pro- 
grammed cell death) in blood cells are controlled by 
many factors [I]. In the last few years, the cell cycle of 
blood cells has gradually become clear. The majority of 
multipotent stem cells and terminally differentiated 
blood cells arrest in the GJG, phase [2]. On the other 
hand, 2040% of committed progenitors of granulocyte- 
macrophages and erythrocytes progress to the S phase 
of the cell cycle [2]. Similarly, the cell cycle of mouse 
myeloid leukemia cells (Ml), the parental strain of Mm1 
cells, is the same as that of committed progenitors and 
the cells are arrested in the G,,/Gl phase by treatment 
with IL-6 [3]. 
Nitric oxide (NO) is a molecule of current interest 
owing to its multiple biological functions [4]. In the im- 
mune system, NO and other nitrogen oxides produced 
by activated macrophages have been shown to be a cyto- 
static and highly cytotoxic agent against tumor cells and 
parasites [5,6]. Cell death occurs in most animal tissues 
at some stage of their development and differentiation. 
NO-producing fibroblasts commit suicide by depression 
of mitochondrial respiration [7]. Similar phenomena 
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have been reported in NO-producing macrophages [8,9]. 
However, recently we observed that Mm1 cells treated 
with IL-6 were not autocytotoxic by nitric oxide produc- 
tion and reversibly proliferate on removal of IL-6 from 
the culture medium (manuscript submitted). In the pres- 
ent report, we show that IL-6-treated Mm1 cells produce 
nitric oxide and accumulate in the early G,+M phase of 
the cell cycle. 
2. Materials and methods 
2.1. Materials 
Reagents and their sources were as follows. (Sigma) NC-methyl-L- 
arginine (L-NMMA); (Calbiochem), vinblastine; demecolcine, tricho- 
statin A and cytochalasin B (Wake Pure Chemical Co. Ltd.); recombi- 
nant human IL-6 was prepared as described previously [lo]. 
2.2. Cell hne and culture 
WEHI-3B was purchased from the Institute for Fermentation, 
Osaka. The Mm1 cells established by Maeda from Ml cells [l l] were 
cultured as described previously [12]. Mm1 cells (5-10 x lo6 cells/l0 cm 
dish) were cultured with IL-6 (100 U/ml) for l-3 days in the presence 
or absence of L-NMMA and drugs. 
2.3. Flow cytometry 
Cells (approximately 2x lo6 cells) were harvested at various times, 
then washed with PBS, fixed with 70% ethanol for 30 min at 4°C and 
stained with propidium iodide containing RNase, using a cell cycle 
staining kit (Boehringer Mannheim). Flow cytometric analysis was 
carried out on a FACSstar plus. At least lo4 cells were measured using 
a standard analysis protocol with a flow rate of 50@min. Histograms 
were stored and files reanalyzed using the CELL-FIT program (Becton 
Dickinson). 
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3. Results and discussion 
Mm1 cells activated with IL-6 for 2 days ceased DNA 
synthesis and produced nitric oxide. The cell cycle of 
Mm1 cells treated with IL-6 was examined by staining 
their DNA. As shown in Fig. lA, approximately 36.6% 
of the cells were in S phase and 14.2% were in the G,+M 
phase. These percentages are similar to those of popula- 
tions of committed macrophage progenitors [2]. On the 
other hand, Mm1 cells treated with IL-6 for 2 and 3 days 
exhibited a significant increase in the percentage of 
G,+M phase cells (Fig. 1). The nitrite concentration of 
culture medium in IL-6-treated Mm1 cells for 2 and 3 
days was 80.2 and 110.5 (nmol/106 cells), respectively. To 
establish where in the G, and Gz phase the cells arrested, 
Mm1 cells were treated with trichostatin A, a histone 
deacetylase inhibitor which blocks the cell cycle at the G, 
and G2 phases [13]. As shown in Fig. 1, 66.3% of Mm1 
cells treated with trichostatin A arrested in the G, phase 
and the percentage of G,+M phase cells was clearly re- 
duced. As WEHI-3B cells are also induced to differen- 
tiate by IL-6 [14], the cell cycle of IL-6-treated cells was 
investigated. As shown in Fig. 1, 87.5% of the cells were 
arrested in the G, phase. Resnitzky reported that the 
majority of M, cells were arrested in the G, phase on 
treatment with IL-6 [3]. Ml and WEHI-3B cells were 
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differentiated, but could not be induced to produce nitric 
oxide by treatment with IL-6 ([12] and data not shown). 
These results indicate that the main checkpoint of the cell 
cycle in Mm1 cells exists in the G, phase and that nitric 
oxide abrogates this G, checkpoint. 
To investigate this, Mm1 cells were treated with IL-6 
in the presence of L-NMMA (competitive inhibitor of 
nitric oxide production). As shown in Fig. 2, percentages 
of G,+M phase cells gradually decreased with the corre- 
sponding increases in addition of L-NMMA. The nitrite 
concentration of culture medium of IL-6-treated Mm1 
cells in the presence of 10 ,uM, 50 ,uM, 100 ,uM and 500 
PM L-NMMA were 101.7, 89.5, 58.9 and 40.3 (nmol/ 
lo6 cells), respectively. These data suggest hat the con- 
centration of nitric oxide correlates with the percentage 
of G,+M phase cells. On the other hand, the percentage 
of GJG, phase cells was markedly increased with treat- 
ment of sodium nitroprusside alone (Fig. 3). It has been 
reported that nitric oxide inhibits DNA synthesis by in- 
activation of ribonucleotide reductase [ 15,161. Therefore. 
this result suggests that SNP alone inhibits DNA synthe- 
sis and blocks the cell cycle prior to the S phase. 
DNA content of the major peak of G,+M phase- 
arrested IL-6-treated Mm1 was 1.76-l .88 times that in 
the cells arrested in the GJG, phase. To identify the 
checkpoint of the cell cycle, Mm1 cells were incubated 
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Fig. 1. Cell cycle changes in Mm1 cells after treatment with IL-6. (A) Flow cytometry charts of Mm1 cells cultured m the absence (a) or in the presence 
of IL-6 (100 U/ml) for 2 days (b) and 3 days (c), and trichostatin A (0.5 @ml) for 1 day (d). (e) Flow cytometry chart of WEHI-3b cells cultured 
with IL-6 (100 U/ml) for 3 days. Cells were stained with PI and analyzed by FACSstar plus as described in section 2. (B) Quantitative assessment 
of the percentages of Mm1 cells remaining in the G,jG, phase, the S phase, and the G?+M phase, evaluated as illustrated in (A). 
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Fig. 2. Effects of L-NMMA on cell cycle in IL-6-treated Mm1 cells. (A) Flow cytometry chart of Mm1 cells treated with IL-6 (100 U/ml) for 3 days 
in the absence (a) or in the presence of 500pM (b), 100pM (c), 50pM (d) and 10pM (e) of L-NMMA. (f) Flow cytometry chart of mM 1 cells cultured 
in the absence of IL-6 for 2 days. The cells were stained with PI and analyzed by FACSstar plus as described in section 2. (B) Quantitative assessment 
of the percentages of Mm1 cells remaining in the GdG, phase, the S phase and the Gt+M phase, evaluated as illustrated in (A). 
with vinblastine, demecolcine or cytochalasin B in the 
presence or absence of IL-6. As shown in Fig. 4, deme- 
colcine and vinblastine completely inhibited the cell cycle 
in the G,+M phase and the DNA content of those cells 
was approximately double that of GJG, phase cells. In- 
terestingly, the cell cycle of Mm1 cells treated with cyto- 
chalasin B was the same as that of IL-6-treated Mm1 
cells (Fig. 4). In the presence of IL-6 (100 U/ml), the cell 
cycle was arrested in the early G,+M phase after treat- 
ment with demecolcine and vinblastine (Fig. 4). It has 
been reported that nitric oxide activates guanylate 
cyclase, increases the level of intracellular c-GMP and 
subsequently relaxes venous smooth muscle. The mech- 
anism is thought to be that the myosin light chain (MLC) 
is phosphorylated by MLC-kinase in a calmodulin- 
dependent manner, inducing the dissociation of myosin 
and actin filaments [17,18]. In addition, it has been 
shown in vitro that actin is ADP-ribosylated by nitric 
oxide and the ADP-ribosylated actin is unable to polym- 
erize [19,20]. These observations and the data in the 
present report suggest hat endogenous nitric oxide acts 
on actin filaments and blocks the cell cycle in the early 
G,+M phase. However, the effect of nitric oxide alone 
on the cell cycle is not sufficient without a signal from 
IL-6. 
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Fig. 3. Effects of SNP on cell cycle in Mm1 cells. (A) Flow cytometry chart of Mm1 cells cultured in the absence (a) or in the presence of 0.01 mM 
(b), 0.1 mM (c) and 1 .O mM (d) of SNP. The cells were stained with PI and analyzed by FACSstar plus as described in section 2. (B) Quantitative 
assessment of the percentages of Mm1 cells remaining in the G$G, phase, the S phase and the G,+M phase, evaluated as illustrated in (A). 
Fig. 4. Identification of the cell cycle checkpoint in IL-6-treated Mm1 cells. Mm1 cells cultured in the absence (a,b) or m the presence of demecolcine 
(0.05 &ml) (c,d), vinblastine (lo-’ M) (e,f), and cytochalasin B (lo-’ M) (g,h) for 3 days without (a,c,e,g) or with IL-6 (100 U/ml) (b,d,f,h). The 
cells were stained with PI and analyzed by FACSstar plus as described in section 2. 
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